Konturek Peter C, Harsch Igor A, Konturek Kathrin, Schink Monic, Zopf Yurdagül
Klinik für Innere Medizin II, Thüringen-Kliniken Saalfeld, Saalfeld, Deutschland.
Klinik für Innere Medizin II, Thüringen-Kliniken, "Georgius Agricola" GmbH, Rainweg 68, 07318, Saalfeld/Saale, Deutschland.
MMW Fortschr Med. 2018 Nov;160(Suppl 5):11-15. doi: 10.1007/s15006-018-1051-6. Epub 2018 Oct 26.
Liver and intestine are in close contact with each other. The risk of damage to the liver increases, when the intestinal barrier is damaged ("leaky gut") .
The review article describes how intestinal bacteria influence the pathogenesis of chronic liver diseases and what treatment options are available.
Intestinal dysbiosis plays an important role in the development of chronic liver diseases such as alcoholic liver disease, nonalcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, and cirrhosis. Intestinal microbial modulating therapy with probiotics, prebiotics or synbiotics shows positive effects. The more precise meaning of this therapeutic approach needs to be clarified in further studies.
肝脏与肠道紧密相连。当肠道屏障受损(“肠漏”)时,肝脏受损的风险会增加。
这篇综述文章描述了肠道细菌如何影响慢性肝病的发病机制以及有哪些可用的治疗选择。
肠道菌群失调在慢性肝病如酒精性肝病、非酒精性脂肪性肝病、原发性胆汁性胆管炎、原发性硬化性胆管炎和肝硬化的发展中起重要作用。使用益生菌、益生元或合生元进行肠道微生物调节治疗显示出积极效果。这种治疗方法的确切意义需要在进一步研究中阐明。